Yaron Barac to Ventricular Remodeling
This is a "connection" page, showing publications Yaron Barac has written about Ventricular Remodeling.
Connection Strength
0.327
-
Barac YD, Emrich F, Krutzwakd-Josefson E, Schrepfer S, Sampaio LC, Willerson JT, Robbins RC, Ciechanover A, Mohr FW, Aravot D, Taylor DA. The ubiquitin-proteasome system: A potential therapeutic target for heart failure. J Heart Lung Transplant. 2017 Jul; 36(7):708-714.
Score: 0.127
-
Malka A, Meerkin D, Barac YD, Malits E, Bachner-Hinenzon N, Carasso S, Ertracht O, Angel I, Shofti R, Youdim M, Abassi Z, Binah O. TVP1022: A Novel Cardioprotective Drug Attenuates Left Ventricular Remodeling After Ischemia/Reperfusion in Pigs. J Cardiovasc Pharmacol. 2015 Aug; 66(2):214-22.
Score: 0.114
-
Abassi ZA, Barac YD, Kostin S, Roguin A, Ovcharenko E, Awad H, Blank A, Bar-Am O, Amit T, Schaper J, Youdim M, Binah O. TVP1022 attenuates cardiac remodeling and kidney dysfunction in experimental volume overload-induced congestive heart failure. Circ Heart Fail. 2011 Jul; 4(4):463-73.
Score: 0.085